These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


649 related items for PubMed ID: 18327804

  • 21. High promoter hypermethylation frequency of p14/ARF in supratentorial PNET but not in medulloblastoma.
    Inda MM, Muñoz J, Coullin P, Fauvet D, Danglot G, Tuñón T, Bernheim A, Castresana JS.
    Histopathology; 2006 Apr; 48(5):579-87. PubMed ID: 16623784
    [Abstract] [Full Text] [Related]

  • 22. DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps.
    Jung AY, Poole EM, Bigler J, Whitton J, Potter JD, Ulrich CM.
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):330-8. PubMed ID: 18268116
    [Abstract] [Full Text] [Related]

  • 23. Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism.
    Candiloro IL, Dobrovic A.
    Cancer Prev Res (Phila); 2009 Oct; 2(10):862-7. PubMed ID: 19789298
    [Abstract] [Full Text] [Related]

  • 24. Hypermethylation of p14 (ARF) may be predictive of colitic cancer in patients with ulcerative colitis.
    Moriyama T, Matsumoto T, Nakamura S, Jo Y, Mibu R, Yao T, Iida M.
    Dis Colon Rectum; 2007 Sep; 50(9):1384-92. PubMed ID: 17665255
    [Abstract] [Full Text] [Related]

  • 25. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
    Lin SY, Yeh KT, Chen WT, Chen HC, Chen ST, Chiou HY, Chang JG.
    Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
    [Abstract] [Full Text] [Related]

  • 26. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
    Xu E, Lai M, Lv B, Xing X, Huang Q, Xia X.
    Biochem Biophys Res Commun; 2004 Nov 19; 324(3):999-1003. PubMed ID: 15485653
    [Abstract] [Full Text] [Related]

  • 27. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer.
    Shen H, Wang L, Spitz MR, Hong WK, Mao L, Wei Q.
    Cancer Res; 2002 Sep 01; 62(17):4992-5. PubMed ID: 12208751
    [Abstract] [Full Text] [Related]

  • 28. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms.
    Silva J, Silva JM, Domínguez G, García JM, Cantos B, Rodríguez R, Larrondo FJ, Provencio M, España P, Bonilla F.
    J Pathol; 2003 Mar 01; 199(3):289-97. PubMed ID: 12579530
    [Abstract] [Full Text] [Related]

  • 29. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
    Liang J, Li Y, Wang N.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr 01; 25(2):183-6. PubMed ID: 18393242
    [Abstract] [Full Text] [Related]

  • 30. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.
    Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB, Herman JG.
    Cancer Res; 2000 Jan 01; 60(1):129-33. PubMed ID: 10646864
    [Abstract] [Full Text] [Related]

  • 31. Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer.
    Lee M, Sup Han W, Kyoung Kim O, Hee Sung S, Sun Cho M, Lee SN, Koo H.
    Pathol Res Pract; 2006 Jan 01; 202(6):415-24. PubMed ID: 16675157
    [Abstract] [Full Text] [Related]

  • 32. Detection of lymph node micrometastases by gene promoter hypermethylation in samples obtained by endosonography- guided fine-needle aspiration biopsy.
    Pellisé M, Castells A, Ginès A, Agrelo R, Solé M, Castellví-Bel S, Fernández-Esparrach G, Llach J, Esteller M, Bordas JM, Piqué JM.
    Clin Cancer Res; 2004 Jul 01; 10(13):4444-9. PubMed ID: 15240535
    [Abstract] [Full Text] [Related]

  • 33. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, MacLeod AR.
    Nat Genet; 2003 Jan 01; 33(1):61-5. PubMed ID: 12496760
    [Abstract] [Full Text] [Related]

  • 34. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.
    Zhang X, Miao X, Tan W, Ning B, Liu Z, Hong Y, Song W, Guo Y, Zhang X, Shen Y, Qiang B, Kadlubar FF, Lin D.
    Gastroenterology; 2005 Aug 01; 129(2):565-76. PubMed ID: 16083713
    [Abstract] [Full Text] [Related]

  • 35. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.
    Tannapfel A, Sommerer F, Benicke M, Weinans L, Katalinic A, Geissler F, Uhlmann D, Hauss J, Wittekind C.
    J Pathol; 2002 Aug 01; 197(5):624-31. PubMed ID: 12210082
    [Abstract] [Full Text] [Related]

  • 36. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma.
    Shieh YS, Shiah SG, Jeng HH, Lee HS, Wu CW, Chang LC.
    Cancer; 2005 Sep 01; 104(5):1013-21. PubMed ID: 15999364
    [Abstract] [Full Text] [Related]

  • 37. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
    Wang G, Hu X, Lu C, Su C, Luo S, Luo ZW.
    Lung Cancer; 2008 Nov 01; 62(2):162-72. PubMed ID: 18468719
    [Abstract] [Full Text] [Related]

  • 38. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population.
    Ezzikouri S, El Feydi AE, Benazzouz M, Afifi R, El Kihal L, Hassar M, Akil A, Pineau P, Benjelloun S.
    Infect Genet Evol; 2009 Sep 01; 9(5):877-81. PubMed ID: 19465161
    [Abstract] [Full Text] [Related]

  • 39. Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors.
    Yin D, Xie D, Hofmann WK, Miller CW, Black KL, Koeffler HP.
    Oncogene; 2002 Nov 28; 21(54):8372-8. PubMed ID: 12447702
    [Abstract] [Full Text] [Related]

  • 40. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
    Hsu HS, Wang YC, Tseng RC, Chang JW, Chen JT, Shih CM, Chen CY, Wang YC.
    Clin Cancer Res; 2004 Jul 15; 10(14):4734-41. PubMed ID: 15269146
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 33.